InvestorsHub Logo
Followers 0
Posts 798
Boards Moderated 0
Alias Born 07/27/2018

Re: None

Monday, 12/03/2018 5:40:48 PM

Monday, December 03, 2018 5:40:48 PM

Post# of 41270
I kind of figure if a company has a good trajectory or a competing edge it doesn't go up. it goes down, until a market maker accrues a dominant amount of shares. Then it goes up and the market maker attempts to leave retail holding the bag. It swings below RSI and the market maker picks it back up again and repeats the cycle of swinging upward. This way the stock price goes up but not in a straight line over it's course. In this way a no fund can accrue more than a 5% foot hold is unhealthy for share price.

The only healthy thing Sintx can do for itself is wean itself off of investment funding and take enough share of the actual in real life implant market to float the company into the future and use profitability for R&D growth. Looking at this, I could care less if SINTX has a bunch of cash on hand since it's not from running a company, besides it buys time and funds to push it toward a profitable company.

All my hopes and dreams for an EPS live with Daniel Chon. A fresh face and a fresh outlook looking to shake things up compared to the years of AMDA slowly bleeding out on the same old path. Glad Sonny cut off his fingers here. Provides incite into Sonny as a good CEO in my opinion. These two guys look like a solid team for what a company fighting the world need to do for survival.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News